## EPAM: EPAM Systems, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.37 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-5.1% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($189.92)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 4, Bearish: 1)

**1. Why a $15 Million Bet on EPAM Looks Smart Amid a 12% One-Year Stock Decline**
- Source: The Globe and Mail | 20260102T050810 | Bullish | Relevance: 100%
- Wishbone Management invested $15.08 million in EPAM Systems, purchasing 100,000 shares in Q3, making it their fourth-largest position. This aggressive move comes as EPAM's stock has declined 12% over the past year, despite strong revenue growth and a positive outlook, suggesting Wishbone sees it as an undervalued opportunity. The investment is noted as a diversification within a concentrated portfolio, focusing on enterprise AI rather than consumer trends.

**2. Why a $15 Million Bet on EPAM Looks Smart Amid a 12% One-Year Stock Decline**
- Source: The Globe and Mail | 20260101T140821 | Bullish | Relevance: 100%
- Wishbone Management invested $15.08 million in EPAM Systems, making it 8.11% of their assets under management, despite the stock declining 12% over the past year. This strategic move highlights EPAM's strong financial performance with increasing revenue and a raised full-year outlook, suggesting a calculated bet on the company's long-term value in digital engineering and AI, rather than a speculative play. The investment represents a diversification within a concentrated portfolio for Wishbone Management.

**3. EPAM Systems (NYSE:EPAM) Stock Rating Upgraded by Zacks Research**
- Source: MarketBeat | 20260101T111325 | Bullish | Relevance: 100%
- Zacks Research has upgraded EPAM Systems (NYSE:EPAM) from a "hold" to a "strong-buy" rating. This upgrade comes as EPAM surpassed quarterly EPS expectations and reported significant revenue growth, alongside the authorization of a $1 billion share repurchase program. The stock currently holds a "Moderate Buy" consensus rating from analysts with an average price target of $208.40.

**4. The Truth About EPAM Systems Inc: Is Wall Street’s Quiet Tech Beast About To Go Viral?**
- Source: AD HOC NEWS | 20260101T062322 | Somewhat-Bullish | Relevance: 100%
- EPAM Systems Inc. is presented as a quiet tech beast stacking wins despite the buzz around AI and Big Tech, focusing on building software, digital platforms, and AI-powered services for major brands. The article explores whether this under-the-radar stock is a game-changer or a trap, highlighting its business model, stock performance, and risks compared to competitors like Globant. It concludes that EPAM is a "smart cop" for long-term, research-heavy investors rather than a viral hype stock.

**5. The Truth About EPAM Systems Inc: Is Wall Street’s Quiet Tech Beast About To Go Viral?**
- Source: AD HOC NEWS | 20260101T060817 | Bullish | Relevance: 100%
- EPAM Systems Inc. is highlighted as a quietly successful tech company specializing in software, digital platforms, and AI-powered services. The article explores whether this "quiet grinder" is an underappreciated investment opportunity for long-term investors or merely an overhyped stock. It dives into EPAM's business model, stock performance, and risks, comparing it to competitors like Globant to assess its true potential.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 8 ($0.41M) |
| Sells | 4 ($0.34M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+0.4%)
- Blackrock Inc.: 8.5% (+4.7%)
- Invesco Ltd.: 7.1% (-4.7%)
- Ameriprise Financial: 4.8% (+28.9%)
- State Street Corpora: 4.2% (-0.1%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.1% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.37 suggests fair value with growth premium. Balance sheet: strong liquidity (3.0x), low leverage (D/E 0.30). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.2B |
| Beta | 1.75 |
| 52W Range | $138.15 - $269.00 |
| Short Interest | 6.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.37 |
| Forward P/E | 16.1 |
| Current P/E | 17.5 |
| YoY Growth | 8.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.2% to -2.9% (-5.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.9pp (needs >4.0% for momentum thesis). AM_20 at -3.4% indicates price below own 20MA trend. Long-term uptrend intact (above SMA200 at 1.18x) but short-term weakness (below SMA20). MACD histogram bearish (-2.12), momentum weakening. RSI neutral at 50. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.87% (CS: 14) | Weak |
| RSI_14 | 49.5 | Neutral |
| MACD Histogram | -2.12 | Bearish |
| vs SMA20 | 0.966x | Below |
| vs SMA50 | 1.068x | Above |
| vs SMA200 | 1.177x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $200.46
- **Stop Loss:** $189.92 (5.3% risk)
- **Target:** $221.54 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 113
- **Position Value:** $22,651.98
- **Portfolio %:** 22.65%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-19 (Est: $3.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.03 | $3.08 | +1.7% |
| 2025Q2 | $2.61 | $2.77 | +6.0% |
| 2025Q1 | $2.27 | $2.41 | +6.1% |
| 2024Q4 | $2.75 | $2.84 | +3.1% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*